Opthea Ltd (CKDXF) stock
Close on Oct 19, 2026Market cap –P/E –Yield –
Opthea Ltd saw revenue fall 80.0% to $25.00K over fiscal 2025. Free cash flow was -$158.66M.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $25.00K
- Net income
- -$162.79M
- EPS, diluted
- -$0.13
- Free cash flow
- -$158.66M
Trading
- Previous close
- $0.01
- Open
- $0.01
- Day's range
- $0.01 – $0.01
- Volume
- 0
Market cap history
Month-end market cap since 2019, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | CKDXF | S&P 500 | Difference | CKDXF per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | 0.0% | +0.6% | −0.6 pts | ||
| 3 months | 0.0% | +3.4% | −3.4 pts | ||
| Year to date | -97.7% | +13.3% | −111.0 pts | ||
| 1 year | -97.7% | +16.6% | −114.3 pts | ||
| 3 years | -97.6% | +86.4% | −184.0 pts | -71.2% | +23.1% |
| 5 years | -99.1% | +81.9% | −180.9 pts | -60.9% | +12.7% |
| 10 years | -98.1% | +318.9% | −417.0 pts | -32.8% | +15.4% |
Eight years at a glance
Fiscal years 2018 to 2025, USD
Revenue
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Opthea filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Opthea
Biological Products, (No Diagnostic Substances)
The provided text consists of XBRL data tags, equity plan member identifiers, and financial statement line codes rather than descriptive narrative text. These items indicate that the company operates in biopharmaceutical development with references to Opthea US Inc and Vegenics Pty Ltd, but the excerpt does not disclose specific products, services, segments, or customer groups.
Company profile, executives and historyOpthea stock: common questions
What is Opthea's stock price?
CKDXF closed at $0.01 on Oct 19, 2026, up 0.00% on the day.
What is CKDXF's P/E ratio?
Opthea lost money over fiscal 2025 (diluted EPS -$0.13), so it has no meaningful P/E ratio.
How much revenue does Opthea make?
Opthea reported revenue of $25.00K for fiscal 2025, down 80.0% from a year earlier.
Does Opthea pay a dividend?
No. Opthea has not paid a cash dividend over the last twelve months.
How has CKDXF stock performed over the past year?
Including dividends, CKDXF returned -97.7% over the past year, against +16.6% for the S&P 500.
Who are Opthea's competitors?
Companies most similar to Opthea by business, industry and size include ENTX, KPRX, SNTI, INMB, ALLO.
See a number that looks wrong?